A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
Status: Recruiting
Location: See all (11) locations...
Study Type: Observational
SUMMARY
To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Newly diagnosed MAC-PD (primary or recurrent) as per the international NTM guideline that requires three-drug antimycobacterial treatment
• Signed and dated informed consent
Locations
United States
Oregon
Oregon Science and Health University
RECRUITING
Portland
Other Locations
Belgium
UZ Leuven
RECRUITING
Leuven
Canada
University of Calgary
RECRUITING
Calgary
Croatia
University Hospital Center Zagreb
RECRUITING
Zagreb
Denmark
Aarhus University Hospital
RECRUITING
Aarhus
Rasmus Rude Laub
RECRUITING
Hellerup
Germany
University Hospital Frankfurt
RECRUITING
Frankfurt
Japan
Fukujuji Hospital
RECRUITING
Tokyo
Netherlands
Radboud University Medical Center
RECRUITING
Nijmegen
Republic of Korea
Seoul National University Hospital
RECRUITING
Seoul
Spain
Hospital Clínic de Barcelona
RECRUITING
Barcelona
Contact Information
Primary
Arthur Lemson, MSc
arthur.lemson@radboudumc.nl
+31634265743
Backup
Wouter Hoefsloot, MSc, PhD
wouter.hoefsloot@radboudumc.nl
+31611072569
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Radboud University Medical Center